<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_UB_Indonesia_screening"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:UB_Indonesia/screening">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:UB_Indonesia/screening&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:UB_Indonesia/screening&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:UB_Indonesia/screening&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:UB_Indonesia/screening" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:UB Indonesia/screening</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2014.igem.org</H3><P><TITLE>iGEM Brawijaya University</TITLE></P><H1 id="logo">Screening</H1><NAV id="nav"><UL><LI><A href="#intro">Intro</A></LI><LI><A href="#one">Background</A></LI><LI><A href="#work">What We Do ?</A></LI><LI><A href="#two">Constructing TALEs</A></LI><LI><A href="#three">Vektor</A></LI><LI><A href="#proto">Prototype</A></LI></UL></NAV><SECTION id="intro" class="main style1 dark fullscreen"><DIV class="content container"><HEADER><H2>Introduction</H2></HEADER><P align="justify">       Cervical cancer is one of the most common cancers in women worldwide, with an estimated global incidence of 470,000 new cases and approximately 233,000 deaths per year. Then, we try to make an idea to build a new prototype for early detection to cervical cancer, especially caused by HPV 18 and HPV 16. From the previous results of the two teams, Calgary Team 2013 and Freiburg Team 2012, we build a new prototype with some combination from those teams. We learn about the prototype sensor from Calgary Team 2012 that consist of detector, linker, and reporter that combined into one small test pack. Then, to make the detector, we learn from Freiburg Team 2012 to constructing a new specific TALEs that can bind to our target sequences and we called it TALE 1 and TALE 2. </P></DIV><A href="#one" class="button style2 down anchored">Next</A></SECTION><SECTION id="one" class="main style1 dark fullscreen"><DIV class="content container"><HEADER><H2>Background</H2></HEADER><P align="justify">TALEs or Transcription Activator-Like Effectors comes from natural bacterial effector proteins used by Xanthomonas sp. to modulate gene transcription in host plants to facilitate bacterial colonization (Boch J and Bogdanove, 2010).The central region of the protein contains tandem repeats of 34 amino acids sequences (termed monomers) that are required for DNA recognition and binding (Kay, 2009). 
                    Here is the natural structure of TALE from Xanthomonas sp. :</P><DIV id="contact"><DIV class="box container small"><DIV class="row half"><DIV class="12u"><P align="center">Figure 1. Structure of TALEs derived from Xanthomonas sp. (Sanjana et al, 2013)</P></DIV></DIV></DIV></DIV></DIV><A href="#work" class="button style2 down anchored">Next</A></SECTION><SECTION id="work" class="main style3 primary"><DIV class="content container"><HEADER><H2>WHAT DID WE DO?</H2><P align="justify">As explained before in the Background, we try to make a prototype based on the concept of <A href="https://2013.igem.org/Team:Calgary">Calgary Team 2013</A>. So we construct a new TALEs that can bind with our target sequences, especially in HPV 18 and HPV 16. For building the detector, we received help from <A href="https://2012.igem.org/Team:Freiburg/Project/Overview">Freiburg Team 2012</A> to construct two new TALEs. First, we search the target sequences with the alignment of whole genome of HPV 18 and HPV 16 via NCBI and MEGA5. We search two target sequences in left side and right side. Here are some works that we’ve done:</P></HEADER></DIV><A href="#two" class="button style2 down anchored">Next</A></SECTION><SECTION id="two" class="main style2 left dark fullscreen"><DIV class="content container"><HEADER><CENTER><H2>CONSTRUCTING TALEs</H2></CENTER></HEADER><P align="center">Based on <A href="https://2012.igem.org/Team:Freiburg/Project/Tal">Freiburg Team 2012 method</A>, we designed our TALE into 2, TALE 1 and TALE 2.</P>
				For TALE 1, We Use: <FONT size="4">                                <A href="http://parts.igem.org/Part:BBa_K747012">(1) BBa_K747012 </A>           <A href="http://parts.igem.org/Part:BBa_K747016">(2) BBa_K747016 </A>           <A href="http://parts.igem.org/Part:BBa_K747042">(3) BBa_K747042 </A>       <A href="http://parts.igem.org/Part:BBa_K747048">(4) BBa_K747048 </A>           <A href="http://parts.igem.org/Part:BBa_K747064">(5) BBa_K747064 </A>        <A href="http://parts.igem.org/Part:BBa_K747091">(6) BBa_K747091 </A></FONT>
				For TALE 2, We Use: <FONT size="4">                                <A href="http://parts.igem.org/Part:BBa_K747012">(1) BBa_K747012 </A>           <A href="http://parts.igem.org/Part:BBa_K747026">(2) BBa_K747026 </A>           <A href="http://parts.igem.org/Part:BBa_K747036">(3) BBa_K747036 </A>       <A href="http://parts.igem.org/Part:BBa_K747052">(4) BBa_K747052 </A>           <A href="http://parts.igem.org/Part:BBa_K747076">(5) BBa_K747076 </A>        <A href="http://parts.igem.org/Part:BBa_K747095">(6) BBa_K747095 </A></FONT></DIV><A href="#three" class="button style2 down anchored">Next</A></SECTION><SECTION id="three" class="main style1 dark fullscreen"><DIV class="content container"><HEADER><CENTER><H2>VECTOR</H2></CENTER></HEADER><DIV class="main style2 left dark fullscreen"><DIV class="content box style2"><P align="justify">For the vector for our TALEs, we received help from Lucas Schneider (member of Freiburg Team 2012) and Nicole Densch (Labmanager from BIOSS, Freiburg). We request the pTALEN and pTAL – TF from BIOSS and sent it to us on Whatman paper. Based on Sanjana et al. (2013), TALE-TFs are constructed by replacing the natural activation domain within the TALE C-term with the synthetic transcription activation domain VP64. </P>
					Figure 2. TALEs can be used to generate custom transcription factors (TALE-TFs) and modulate the transcription of endogenous genes from the genome (Sanjana et al., 2013)
				</DIV></DIV><DIV class="main style2 right dark fullscreen"><DIV class="content box style2"><P align="justify">TALENs are constructed by fusing a C-term truncation (+63aa) of the TALE DNA binding domain with the non-specific FokI endonuclease catalytic domain. TALENs form dimers through binding to two target sequences separated by ~17 bases (Sanjana et al., 2013).</P><P align="justify">Figure 3. TALE nucleases (TALENs) can be used to generate site-specific double strand breaks to facilitate genome editing through non-homologous repair or homology-directed repair (Sanjana et al., 2013)</P></DIV></DIV></DIV><A href="#proto" class="button style2 down anchored">Next</A></SECTION><SECTION id="proto" class="main style1 dark fullscreen"><DIV class="content container"><HEADER><H2>Prototype</H2></HEADER></DIV><A href="#intro" class="button style2">Intro</A></SECTION><FOOTER id="footer"><UL class="actions"><LI><A href="https://www.twitter.com/igem_ub" class="icon fa-twitter"><SPAN class="label">Twitter</SPAN></A></LI><LI><A href="https://www.facebook.com/igem_ub" class="icon fa-facebook"><SPAN class="label">Facebook</SPAN></A></LI><LI><A href="#" class="icon fa-google-plus"><SPAN class="label">Google+</SPAN></A></LI><LI><A href="#" class="icon fa-dribbble"><SPAN class="label">Dribbble</SPAN></A></LI><LI><A href="#" class="icon fa-pinterest"><SPAN class="label">Pinterest</SPAN></A></LI><LI><A href="#" class="icon fa-instagram"><SPAN class="label">Instagram</SPAN></A></LI></UL><UL class="menu"><LI>© Untitled</LI><LI>Design: <A href="http://html5up.net">HTML5 UP</A></LI></UL></FOOTER><DIV class="printfooter">
Retrieved from &quot;<A href="http://2014.igem.org/Team:UB_Indonesia/screening">http://2014.igem.org/Team:UB_Indonesia/screening</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:UB_Indonesia/screening" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:UB_Indonesia/screening" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:UB_Indonesia/screening&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:UB_Indonesia/screening&amp;oldid=215740" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2014.igem.org:Privacy_policy" title="2014.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2014.igem.org:General_disclaimer" title="2014.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>